Similarly, in patients with type 2 diabetes and MASLD, a 12-week regimen of the carnitine-orotate complex (824 mg, three times daily) led to reduced serum ALT levels and decreased liver fat, as evaluated by CT, in a sample of 78 patients (25877813). Here, GPT is linked to type 2 diabetes mellitus.